KEGG   PATHWAY: gvr04650
Entry
gvr04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Galeopterus variegatus (Sunda flying lemur)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
gvr04650  Natural killer cell mediated cytotoxicity
gvr04650

Other DBs
GO: 0042267
Organism
Galeopterus variegatus (Sunda flying lemur) [GN:gvr]
Gene
103581671  RAET1E; LOW QUALITY PROTEIN: NKG2D ligand 4 [KO:K07987]
103581673  [KO:K07986]
103581715  [KO:K06463]
103581832  PRF1; perforin-1 [KO:K07818]
103582026  [KO:K24233]
103582470  [KO:K07360] [EC:2.7.10.2]
103582693  SH2D1A; SH2 domain-containing protein 1A isoform X1 [KO:K07990]
103583388  [KO:K19663] [EC:2.7.11.13]
103583500  [KO:K06856]
103584029  [KO:K05415]
103585050  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 [KO:K04446]
103585172  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
103585244  SYK; tyrosine-protein kinase SYK [KO:K05855] [EC:2.7.10.2]
103585463  PIK3R3; LOW QUALITY PROTEIN: phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
103585789  TNFSF10; tumor necrosis factor ligand superfamily member 10 [KO:K04721]
103585995  IFNGR2; interferon gamma receptor 2 [KO:K05133]
103585996  IFNAR1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
103585997  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
103586398  PTPN6; tyrosine-protein phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
103586514  SH3BP2; SH3 domain-binding protein 2 [KO:K07984]
103586572  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
103586784  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
103587215  SHC4; SHC-transforming protein 4 [KO:K17449]
103587883  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
103588094  [KO:K07293] [EC:3.1.3.48]
103589329  NRAS; GTPase NRas [KO:K07828]
103589434  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
103589530  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
103590058  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
103590618  RAF1; RAF proto-oncogene serine/threonine-protein kinase [KO:K04366] [EC:2.7.11.1]
103591114  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [KO:K04348] [EC:3.1.3.16]
103591210  [KO:K01353] [EC:3.4.21.79]
103591211  [KO:K01353] [EC:3.4.21.79]
103591212  [KO:K01353] [EC:3.4.21.79]
103591435  IFNGR1; interferon gamma receptor 1 [KO:K05132]
103591521  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
103592192  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
103592383  TNF; tumor necrosis factor [KO:K03156]
103592387  NCR3; LOW QUALITY PROTEIN: natural cytotoxicity triggering receptor 3 [KO:K06743]
103592524  TNFRSF10A; tumor necrosis factor receptor superfamily member 10A [KO:K04722]
103592574  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
103592811  TYROBP; TYRO protein tyrosine kinase-binding protein [KO:K07992]
103592812  HCST; hematopoietic cell signal transducer isoform X1 [KO:K07988]
103593281  PTPN11; tyrosine-protein phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
103593345  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
103593683  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
103594082  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
103594183  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
103594756  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
103594881  BID; BH3-interacting domain death agonist [KO:K04726]
103594929  LCK; tyrosine-protein kinase Lck isoform X1 [KO:K05856] [EC:2.7.10.2]
103595200  PTK2B; protein-tyrosine kinase 2-beta [KO:K05871] [EC:2.7.10.2]
103595586  LAT; linker for activation of T-cells family member 1 isoform X1 [KO:K07362]
103595634  ICAM2; intercellular adhesion molecule 2 [KO:K06523]
103596129  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
103596180  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
103596552  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
103596898  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
103597255  VAV3; guanine nucleotide exchange factor VAV3 [KO:K05730]
103598039  [KO:K05414]
103598040  [KO:K05414]
103598043  [KO:K05414]
103598044  [KO:K05414]
103598106  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
103598210  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
103598251  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
103599334  ITGB2; integrin beta-2 [KO:K06464]
103599442  [KO:K06742]
103599501  KRAS; GTPase KRas [KO:K07827]
103599527  VAV1; proto-oncogene vav [KO:K05730]
103599669  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
103599847  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
103600170  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
103600233  SHC2; SHC-transforming protein 2 [KO:K17447]
103600263  [KO:K04409] [EC:2.7.11.1]
103600324  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
103600561  [KO:K06728]
103600562  KLRD1; natural killer cells antigen CD94 [KO:K06516]
103600564  [KO:K24233]
103600565  [KO:K06541]
103601494  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
103601657  NCR1; natural cytotoxicity triggering receptor 1 [KO:K06741]
103601908  CD247; T-cell surface glycoprotein CD3 zeta chain [KO:K06453]
103604521  PPP3R2; calcineurin subunit B type 2 isoform X1 [KO:K06268]
103605815  [KO:K04687]
103605950  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
103606065  [KO:K07985]
103606318  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
103606391  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
103606603  CD244; natural killer cell receptor 2B4 [KO:K06582]
103606671  [KO:K06856]
103607184  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
103607357  [KO:K06856]
103607480  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
103607777  VAV2; guanine nucleotide exchange factor VAV2 [KO:K05730]
103608083  SHC3; SHC-transforming protein 3 [KO:K17448]
103608098  [KO:K07986]
103608099  [KO:K07986]
103608197  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
103608454  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
103609616  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
103609732  [KO:K04687]
103609769  [KO:K06856]
103609839  [KO:K04722]
103609847  [KO:K05415]
103609850  [KO:K05415]
103610260  [KO:K06479]
103610308  [KO:K07360] [EC:2.7.10.2]
103610480  [KO:K06742]
103610513  HRAS; GTPase HRas isoform X1 [KO:K02833]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
gvr04010  MAPK signaling pathway
gvr04020  Calcium signaling pathway
gvr04060  Cytokine-cytokine receptor interaction
gvr04210  Apoptosis
gvr04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system